Stay updated on Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has updated to version v2.13.3, adding 'Results Submitted' while removing 'No Results Posted' from the previous version v2.13.2.
    Difference
    0.5%
    Check dated 2024-12-14T23:23:02.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T20:33:46.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has added new features, while several detailed data fields and options for downloading study information have been removed.
    Difference
    4%
    Check dated 2024-11-23T05:45:58.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Several key health-related links, including those for ovarian cancer and related resources, have been removed from the website.
    Difference
    0.6%
    Check dated 2024-11-16T01:21:45.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with numerous new links added related to ovarian cancer and treatment options, while the previous version 2.12.1 has been removed.
    Difference
    4%
    Check dated 2024-11-08T19:08:04.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:37:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.